Global Human Oocyte Cryopreservation Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global Human Oocyte Cryopreservation Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Human Oocyte Cryopreservation market size was valued at US$ 84.4 million in 2024 and is forecast to a readjusted size of USD 213 million by 2031 with a CAGR of 14.6% during review period.

Human oocyte cryopreservation (egg freezing) is a procedure to preserve female eggs (oocytes). The eggs are extracted, frozen and stored. The purpose of the procedure is to give women the option of thawing, fertilizing and transplanting the eggs into the uterus as embryos to promote future pregnancy.

Oocyte cryopreservation refers to the technology of cooling human oocytes and storing them in liquid nitrogen (generally stored in liquid nitrogen at -196°C), resuscitating (thawing) them when needed, and ensuring that the oocytes are alive and functioning normally. It is a derivative technology of assisted reproductive technology, mainly used to treat infertility and preserve female fertility.

The driving factors of the oocyte cryopreservation market mainly include the following aspects:

Technological progress

The continuous improvement and maturity of oocyte cryopreservation technology has improved the recovery rate and survival rate of frozen oocytes, thereby increasing the clinical application prospects of this technology and driving the development of the market.

Changes in fertility concepts

The changes in modern women's fertility concepts and the intensification of the trend of late marriage and late childbearing have led more and more women to choose oocyte cryopreservation technology to maintain fertility and provide guarantees for future fertility plans.

Growth in medical demand

With the improvement of medical standards and people's attention to reproductive health, more and more medical institutions and patients have begun to pay attention to oocyte cryopreservation technology, which has promoted the rapid development of the market.

Policy support

The support policies of some countries and regions for assisted reproductive technology, as well as the improvement of relevant laws and regulations, have provided a good policy environment for the development of oocyte cryopreservation technology.

Unlike sperm, oocytes are larger and contain a lot of water, which makes it easier to form ice crystals that may damage the eggs during the freezing process. In addition, egg extraction is not easy and the number is scarce, so the selection of protective agents during the freezing process is also more demanding. These factors have made egg freezing one of the difficulties in freezing technology.

However, with the continuous advancement of technology, the success rate of oocyte cryopreservation has been significantly improved. International clinical trials have proven that frozen eggs can be stored for at least ten years, and they still have the ability to conceive after thawing, can form healthy embryos, and can normally conceive babies. This has led more and more women to choose to preserve their future reproductive ability through oocyte cryopreservation technology, that is, to buy a "fertility insurance".

In general, oocyte cryopreservation technology provides an effective option for women who want to preserve their fertility, and also provides new possibilities for the development of assisted reproductive technology.

This report is a detailed and comprehensive analysis for global Human Oocyte Cryopreservation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Human Oocyte Cryopreservation market size and forecasts, in consumption value ($ Million), 2020-2031

Global Human Oocyte Cryopreservation market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Human Oocyte Cryopreservation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Human Oocyte Cryopreservation market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Human Oocyte Cryopreservation

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Human Oocyte Cryopreservation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Anova Fertility, CCRM IVF, Chill, CREATE Fertility, Extend Fertility, HRC Fertility, IVF Australia, Kindbody, London Women’s Clinic, Manchester Fertility, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Human Oocyte Cryopreservation market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Slow-cooling Method
Flash-freezing Process (Vitrification)

Market segment by Application
25-30 Year Old Female
30-35 Year Old Female
35-40 Year Old Female
Others

Market segment by players, this report covers
Anova Fertility
CCRM IVF
Chill
CREATE Fertility
Extend Fertility
HRC Fertility
IVF Australia
Kindbody
London Women’s Clinic
Manchester Fertility
Mayo Clinic
Melbourne IVF
Monash IVF
Pacific Fertility Center-Los Angeles (PFCLA)
PIVET
Prelude Fertility

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Human Oocyte Cryopreservation product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Human Oocyte Cryopreservation, with revenue, gross margin, and global market share of Human Oocyte Cryopreservation from 2020 to 2025.

Chapter 3, the Human Oocyte Cryopreservation competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Human Oocyte Cryopreservation market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Human Oocyte Cryopreservation.

Chapter 13, to describe Human Oocyte Cryopreservation research findings and conclusion.